Welcome to This Week in Urology. This week we're covering 10 notable papers spanning major updates in prostate cancer management, new data on benign conditions like BPH and recurrent UTIs, and key considerations in complex oncologic and reconstructive surgery. Let's dive in.

This week's papers:

1. How Will PSMAddition Impact the Management of Prostate Cancer? — European urology focus 2026
2. Urethral Complications After Masculinizing Genital Gender-affirming Surgery. — European urology focus 2026
3. Regulating Innovation: Why the European Union Artificial Intelligence Act Matters for Urologists-Recommendations from the EAU AI Working Group. — European urology 2026
4. Nephroureterectomy for upper tract urothelial carcinoma recurrence in bladder cancer patients treated with radical cystectomy: a multicentric propensity score matched analysis on predictors, practice patterns and survival outcomes. — World journal of urology 2026
5. Vaginal Estrogen Use Reduces Serious Adverse Outcomes in Women of All Age Groups With Recurrent Urinary Tract Infection: An Epic Cosmos Database Analysis. — Urology 2026
6. Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity. — The Journal of urology 2026
7. Delphi consensus on ex vivo fluorescence confocal microscopy in robot-assisted radical prostatectomy. — BJU international 2026
8. Zenflow spring system for benign prostatic hyperplasia - 24 month outcomes of the ZEST pilot studies. — Prostate cancer and prostatic diseases 2026
9. Safety, Hemostasis, and Surgical Precision: Reconsidering Tranexamic Acid in Contemporary Urologic Surgery. — European urology 2026
10. Longitudinal Evolution of Uroflowmetry Patterns from Childhood to Puberty After Hypospadias Repair: A 12-Year Cohort Study. — Urology 2026

Listen at AudioScholar